Covid Inquiry: Mistake not to consider range of pandemics – David Cameron
David Cameron says “group think” meant government focused on flu pandemics, rather than other diseases.
Similar Posts
AI-designed drug for inflammatory bowel disease enters human clinical trials: ‘A significant need’
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Vaping – is it a risk-free option?
Colourful gadgets and fruity flavours are popular, but what’s really known about their health effects?
Colorectal cancer is now leading cause of death among young adults with the disease: American Cancer Society
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Exciting new cancer drug kinder than chemotherapy
Arthur, 11, was one of the first in the UK to try blinatumomab, for his type of blood cancer.
Reckitt Benckiser unit recalls possibly contaminated baby formula powder, FDA says
Reckitt/Mead Johnson Nutrition has voluntarily recalled certain Nutramigen Hypoallergenic Infant Formula Powder products due to possible Cronobacter sakazakii contamination. Courtesy: Reckitt/Mead Johnson Baby formula maker Reckitt Benckiser’s Mead Johnson Nutrition has voluntarily chosen to recall certain batches of baby formula powder due to possible bacterial contamination, according to the U.S. Food and Drug Administration. The…
Pharma had a year full of firsts
Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand for costly but highly effective treatments from Novo Nordisk…